
Injectable
GLP-1 receptor agonist — clinical gold standard for sustained weight loss.
Price
$199.00
Optym AI
Your personal product assistant
Optym AI shares general educational info and typical starting-dose ranges — not medical advice. Your licensed OptymHealth provider sets your actual dose after intake.
Select option
FDA-Registered
Compounded by U.S. pharmacies
Free Shipping
Discreet, 3–5 day delivery
Semaglutide is a GLP-1 receptor agonist that has become one of the most prescribed medications for medical weight management worldwide. Known under the brand names Ozempic® and Wegovy®, compounded Semaglutide offers the same active molecule at a fraction of the cost. It works by mimicking the incretin hormone GLP-1, which regulates appetite, slows gastric emptying, and promotes satiety — helping patients achieve sustainable weight loss alongside lifestyle modifications.
Proven Efficacy
Patients in clinical trials lost an average of 15–17% of their body weight.
Appetite Control
Significantly reduces hunger and cravings by acting on brain receptors that control satiety.
Cardiovascular Benefits
Studies show reduced risk of major cardiovascular events in overweight patients.
Convenient Weekly Injection
One simple subcutaneous injection per week fits easily into any routine.
Semaglutide activates GLP-1 receptors in the brain and gut, slowing stomach emptying and reducing appetite signals. This helps you feel full longer, eat less naturally, and achieve steady, sustainable weight loss.
After you complete the intake, a licensed provider reviews your medical history and goals to determine if Injectable Semaglutide is appropriate for you. If approved, your prescription is sent to a partner compounding pharmacy and shipped directly to your door with full dosing instructions and supplies as needed.
Administered via subcutaneous injection as directed by your provider. Detailed injection training and supplies are included with your order. Your provider will personalize the dose and titration schedule for your goals.
Side effects are generally mild and may include injection-site reactions, mild headache, or temporary GI changes depending on the therapy. Discuss any new symptoms with your provider. Injectable Semaglutide is not appropriate for everyone — your provider will screen for contraindications before prescribing.